Danish Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Novo Nordisk

Market Cap: DKK 2.1t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Genmab

Market Cap: DKK 84.9b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Zealand Pharma

Market Cap: DKK 26.6b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Bavarian Nordic

Market Cap: DKK 13.6b

Develops, manufactures, and supplies life-saving vaccines.

H. Lundbeck

Market Cap: DKK 35.3b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Gubra

Market Cap: DKK 8.7b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

Stenocare

Market Cap: DKK 20.2m

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally.

Pharma Equity Group

Market Cap: DKK 152.2m

Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement.

ALK-Abelló

Market Cap: DKK 40.0b

Operates as an allergy solutions company in Europe, North America, and internationally.

BioPorto

Market Cap: DKK 637.4m

An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.

Strategic Partners

Market Cap: DKK 40.9m

Does not have significant operations.

ChemoMetec

Market Cap: DKK 9.1b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.